← Back to patent-cliff list
水杨酸甲酯/l-薄荷醇/维生素E/DL-樟脑
Tier C — Watch / tradeMethyl Salicylate/Levomenthol/Vitamin E/DL-Camphor
-
Originator
2013
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：KOR1、TRPM8
Indications (approved)：疼痛
Regional status
US
-
EU
-
China
批准上市
2013-11-30
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Methyl Salicylate/Levomenthol/Vitamin E/DL-Camphor?
Approved indications include: 疼痛.
When does the Methyl Salicylate/Levomenthol/Vitamin E/DL-Camphor patent expire?
No public expiry year is available for Methyl Salicylate/Levomenthol/Vitamin E/DL-Camphor yet; this page updates once verified.
How do I get a quote for Methyl Salicylate/Levomenthol/Vitamin E/DL-Camphor intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24